Aspira Pathlab Reports Strong Profit Growth and Revenue Surge in March 2025 Results
Aspira Pathlab & Diagnostics has announced its financial results for the quarter ending March 2025, showcasing a substantial increase in Profit After Tax (PAT) to Rs 1.10 crore, alongside net sales of Rs 11.19 crore for the past six months, indicating strong operational performance and demand for its services.
Aspira Pathlab & Diagnostics has reported its financial results for the quarter ending March 2025, revealing notable developments in its performance metrics. The company has demonstrated a significant increase in Profit After Tax (PAT), which reached Rs 1.10 crore, reflecting a year-on-year growth of 188.71%. This positive trend in profitability indicates a strong operational performance over the recent period.In terms of revenue, Aspira Pathlab reported net sales of Rs 11.19 crore for the latest six months, marking a year-on-year growth of 53.71%. This upward trajectory in sales suggests a robust demand for the company's services within the healthcare sector.
Additionally, the PAT for the latest six months has surpassed the preceding twelve-month period, which recorded a loss of Rs 0.27 crore. This shift highlights a significant turnaround in the company's financial health, as it has already exceeded its previous year's profitability within just half a year.
Overall, Aspira Pathlab's recent financial results reflect a positive trajectory in both profitability and sales, leading to an adjustment in its evaluation.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
